Anna Gooch, PhD, serves as Chief Scientific Officer at SymbioCellTech, LLC, since 2013. Previously, Anna held the position of Clinical Operations Manager at AlloCure from 2008 to 2010, where responsibilities included overseeing a successful Phase 1 Clinical trial for a stem cell-based preventative treatment for Acute Kidney Injury (AKI) and facilitating Tech Transfer for a subsequent Phase 2 Clinical trial. Anna earned a Doctor of Philosophy in Cellular Viral Molecular Biology from the University of Utah and a Bachelor of Arts in English from Stephens College.
This person is not in any offices